Millennium Management’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
Other funds holding GPCR
BBA
Millennium Management's GPCR Position: Q3 2026 in Review
Millennium Management reduced its Structure Therapeutics (GPCR) stake by 9.9% in Q3 2026, selling an estimated $417K and leaving 80,675 shares worth $2.52M. The position accounts for ﹤0.01% of the portfolio, ranked #3702.
Millennium Management first reported a position in GPCR in Q1 2023 and has held it in 15 quarters since. The position peaked at $44.7M in Q2 2024. 171 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.
- Millennium Management held 80,675 shares of Structure Therapeutics worth $2.52M as of Q3 2026.
- Millennium Management sold 8,893 Structure Therapeutics shares in Q3 2026, an estimated $417K.
- Structure Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #3702 holding.
- Millennium Management first reported a position in Structure Therapeutics in Q1 2023 and has held it in 15 quarters since.
- Millennium Management's Structure Therapeutics position peaked at $44.7M in Q2 2024.
- 171 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.